KAITLYN GOSS: Open Payments
NPI 1386307916 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 88 payments from 28 companies in 2025. Trend: 2023 $1,454 · 2024 $2,342 · 2025 $2,732
Food & beverage: $1,535Long term medical supply or device loan: $1,097Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $1,206 |
| Tempus AI, Inc | 11 | $204 |
| Regeneron Healthcare Solutions, Inc. | 11 | $178 |
| ABBVIE INC. | 8 | $167 |
| PFIZER INC. | 6 | $122 |
| Incyte Corporation | 2 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $54 |
Products named: KISQALI, XT CDX, EPKINLY, LIBTAYO, ENHERTU, LYNOZYFIC, PLUVICTO, ZYNLONTA.
Industry payments across TX — which companies pay providers there.
